No Data
Executive Reshuffles: JPM, QCOM, DVN and LTC
Bristol-Myers Squibb Notified Century Therapeutics On Dec 12 To Terminate Collaboration Agreement, Effective March 12, 2025; Co To Evaluate Opportunities In AML And Multiple Myeloma In The Context Of The Ongoing Strategic Review Of Century's...
Weekly Buzz: Tech stocks hit high scores on ominous day
Short Sellers Boost Bets Against Energy Stocks as Prices Fall
Drug Price Hikes Unsupported By Evidence Cost US $815 Million: ICER Report
Market Mixed on Friday the 13th | Livestock